Review



smbm basal medium  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Lonza smbm basal medium
    Smbm Basal Medium, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smbm+basal+medium/pm40384490-111-11-14
    Average 90 stars, based on 1 article reviews
    smbm basal medium - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Gene expression modulation in human aortic smooth muscle cells under induced physiological mechanical stretch
    Article Snippet: .. The cells were cultured in two types of media, Smooth Muscle Cell Growth Medium (SmGM2, Lonza, CC-3182) for initial cell proliferation and Basal Medium (SmBM, Lonza, CC-3181) to induce cell differentiation into a contractile phenotype within 5 days. ..

    Article Title: 44th Congress of the Société de Biomécanique.
    Article Snippet: .. Then, the SMC were cultured one week more in a basal medium (SmBM, Lonza), containing low (2%) FBS and 0.04% heparin, according to the manufacturer’s instructions. ..

    Article Title: Stiffness sensing by smooth muscle cells: Continuum mechanics modeling of the acto-myosin role.
    Article Snippet: .. Then, ASMCs were cultured one week more in a basal medium (SmBM, Lonza), containing low (2%) FBS and 0.04% heparin, in order to preserve a contractile phenotype. .. Once they reached 50-70% confluence, a standard cell detachment protocol was used by applying a trypsin treatment with a low trypsin–EDTA solution (0.025% trypsin and 0.75 mM EDTA (1X), Sigma) to break down the focal adhesions in the culture dish without damaging the cells.

    Article Title: Atomic Force Microscopy Stiffness Mapping in Human Aortic Smooth Muscle Cells.
    Article Snippet: .. Then, the SMC were cultured one week more in a basal medium (SmBM, Lonza), containing low (2%) fetal bovine serum and 0.04% heparin, according to the manufacturer’s instructions in order to preserve a contractile phenotype. .. Once they reached 70–80% confluence, we used a standard cell detachment protocol using a trypsin treatment with a low trypsin – ethylenediaminetetraacetic acid solution (0.025% Trypsin and 0.75 mM ethylenediaminetetraacetic acid (1X), Sigma, Saint Quentin Fallavier, France) to break down the focal adhesions in the culture dish without damaging the cells.

    Article Title: Regulation of SMC traction forces in human aortic thoracic aneurysms
    Article Snippet: .. Then, SMCs were cultured one week more in a basal medium (SmBM, Lonza), without FBS and containing 0.04% heparin for differentiation. .. Once they reached 50–70% confluence, we used a standard cell detachment protocol using a trypsin treatment with a low trypsin—EDTA solution (0.025% Trypsin and 0.75 mM EDTA (1X), Sigma) to break down the focal adhesions in the culture dish without damaging the cells.

    Cell Differentiation:

    Article Title: Gene expression modulation in human aortic smooth muscle cells under induced physiological mechanical stretch
    Article Snippet: .. The cells were cultured in two types of media, Smooth Muscle Cell Growth Medium (SmGM2, Lonza, CC-3182) for initial cell proliferation and Basal Medium (SmBM, Lonza, CC-3181) to induce cell differentiation into a contractile phenotype within 5 days. ..

    Incubation:

    Article Title: miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development
    Article Snippet: Images were obtained and analysed by confocal microscopy (Leica SP5, Argon laser). .. Human aortic SMC (hASMCs) and human AoECs were propagated in growth media (SmGM-2 (for hASMC) and EBM-2 (for AoEC); Lonza) with 5% fetal bovine serum (FBS) per standard protocols (Lonza; passage no. 4–5). hASMC were incubated in basal medium (SmBM) for 48 h before treatment/transfection, and other lines were serum-starved overnight before treatment/transfection. .. RAW 264.7 cells (ATCC) were propagated in DMEM+10% FBS.



    Similar Products

    smbm basal medium  (Lonza)
    90
    Lonza smbm basal medium
    Smbm Basal Medium, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smbm+basal+medium/pm40384490-111-11-14
    Average 90 stars, based on 1 article reviews
    smbm basal medium - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    smooth muscle cell basal medium smbm  (Lonza)
    90
    Lonza smooth muscle cell basal medium smbm
    Smooth Muscle Cell Basal Medium Smbm, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smgm+2+medium/pm40354984-55-9-14
    Average 90 stars, based on 1 article reviews
    smooth muscle cell basal medium smbm - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    basal medium smbm  (Lonza)
    90
    Lonza basal medium smbm
    Basal Medium Smbm, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smgm+2+medium/pmc11682279-179-22-25
    Average 90 stars, based on 1 article reviews
    basal medium smbm - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    smooth muscle cell basal medium smbm cc-3181  (Lonza)
    90
    Lonza smooth muscle cell basal medium smbm cc-3181
    Pentose phosphate pathway (PPP) enzyme 6-phosphogluconate dehydrogenase ( 6PGD ) is upregulated aberrantly in the neointimal layer of diseased human coronary arteries with extensive intimal hyperplasia (IH). (A) Representative immunohistochemical staining of 6PGD in cross-sections from human coronary arteries with or without severe IH lesions. Negative control staining followed the same procedures, with the exception that the primary antibody was omitted. Dashed lines highlight the internal and external elastic laminae (EEL). Tunica intima ( Int ), media ( M ), and adventitia ( Adv ) are annotated, respectively. (B) The quantification of 6PGD expression level in tunica intima area and tunica media area. Positive staining was assessed based on colorimetric intensity per image field, quantified by averaging three sections from each sample. The resulting averages from all four unique donors (each including healthy vs diseased arterial segments with severe IH) were then further averaged, as illustrated in the scatter plots. (C) Representative confocal images of 6PGD (red channel) and vascular <t>smooth</t> <t>muscle</t> <t>cell</t> (VSMC) marker α smooth muscle actin ( α-SMA ) (green channel) costaining in healthy vs diseased (with IH lesions) human coronary arteries. Student t test: ∗∗ P < .01, ∗∗∗ P < .001. Mag , magnification.
    Smooth Muscle Cell Basal Medium Smbm Cc 3181, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smgm+2+medium/pmc11420449-49-7-24
    Average 90 stars, based on 1 article reviews
    smooth muscle cell basal medium smbm cc-3181 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    smooth muscle cell basal medium (smbm)  (Lonza)
    90
    Lonza smooth muscle cell basal medium (smbm)
    Pentose phosphate pathway (PPP) enzyme 6-phosphogluconate dehydrogenase ( 6PGD ) is upregulated aberrantly in the neointimal layer of diseased human coronary arteries with extensive intimal hyperplasia (IH). (A) Representative immunohistochemical staining of 6PGD in cross-sections from human coronary arteries with or without severe IH lesions. Negative control staining followed the same procedures, with the exception that the primary antibody was omitted. Dashed lines highlight the internal and external elastic laminae (EEL). Tunica intima ( Int ), media ( M ), and adventitia ( Adv ) are annotated, respectively. (B) The quantification of 6PGD expression level in tunica intima area and tunica media area. Positive staining was assessed based on colorimetric intensity per image field, quantified by averaging three sections from each sample. The resulting averages from all four unique donors (each including healthy vs diseased arterial segments with severe IH) were then further averaged, as illustrated in the scatter plots. (C) Representative confocal images of 6PGD (red channel) and vascular <t>smooth</t> <t>muscle</t> <t>cell</t> (VSMC) marker α smooth muscle actin ( α-SMA ) (green channel) costaining in healthy vs diseased (with IH lesions) human coronary arteries. Student t test: ∗∗ P < .01, ∗∗∗ P < .001. Mag , magnification.
    Smooth Muscle Cell Basal Medium (Smbm), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smgm+2+medium/pm38994980-55-16-24
    Average 90 stars, based on 1 article reviews
    smooth muscle cell basal medium (smbm) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    smooth muscle cell growth basal medium (smbm)  (Lonza)
    90
    Lonza smooth muscle cell growth basal medium (smbm)
    Pentose phosphate pathway (PPP) enzyme 6-phosphogluconate dehydrogenase ( 6PGD ) is upregulated aberrantly in the neointimal layer of diseased human coronary arteries with extensive intimal hyperplasia (IH). (A) Representative immunohistochemical staining of 6PGD in cross-sections from human coronary arteries with or without severe IH lesions. Negative control staining followed the same procedures, with the exception that the primary antibody was omitted. Dashed lines highlight the internal and external elastic laminae (EEL). Tunica intima ( Int ), media ( M ), and adventitia ( Adv ) are annotated, respectively. (B) The quantification of 6PGD expression level in tunica intima area and tunica media area. Positive staining was assessed based on colorimetric intensity per image field, quantified by averaging three sections from each sample. The resulting averages from all four unique donors (each including healthy vs diseased arterial segments with severe IH) were then further averaged, as illustrated in the scatter plots. (C) Representative confocal images of 6PGD (red channel) and vascular <t>smooth</t> <t>muscle</t> <t>cell</t> (VSMC) marker α smooth muscle actin ( α-SMA ) (green channel) costaining in healthy vs diseased (with IH lesions) human coronary arteries. Student t test: ∗∗ P < .01, ∗∗∗ P < .001. Mag , magnification.
    Smooth Muscle Cell Growth Basal Medium (Smbm), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smgm+2+medium/pmc11208054__atv___44___1570___s002-14-10-17
    Average 90 stars, based on 1 article reviews
    smooth muscle cell growth basal medium (smbm) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    smbm basal medium cc-3181  (Lonza)
    90
    Lonza smbm basal medium cc-3181
    Pentose phosphate pathway (PPP) enzyme 6-phosphogluconate dehydrogenase ( 6PGD ) is upregulated aberrantly in the neointimal layer of diseased human coronary arteries with extensive intimal hyperplasia (IH). (A) Representative immunohistochemical staining of 6PGD in cross-sections from human coronary arteries with or without severe IH lesions. Negative control staining followed the same procedures, with the exception that the primary antibody was omitted. Dashed lines highlight the internal and external elastic laminae (EEL). Tunica intima ( Int ), media ( M ), and adventitia ( Adv ) are annotated, respectively. (B) The quantification of 6PGD expression level in tunica intima area and tunica media area. Positive staining was assessed based on colorimetric intensity per image field, quantified by averaging three sections from each sample. The resulting averages from all four unique donors (each including healthy vs diseased arterial segments with severe IH) were then further averaged, as illustrated in the scatter plots. (C) Representative confocal images of 6PGD (red channel) and vascular <t>smooth</t> <t>muscle</t> <t>cell</t> (VSMC) marker α smooth muscle actin ( α-SMA ) (green channel) costaining in healthy vs diseased (with IH lesions) human coronary arteries. Student t test: ∗∗ P < .01, ∗∗∗ P < .001. Mag , magnification.
    Smbm Basal Medium Cc 3181, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/basal+medium+smbm/smgm+2+medium/pmc11165511-286-5-9
    Average 90 stars, based on 1 article reviews
    smbm basal medium cc-3181 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Pentose phosphate pathway (PPP) enzyme 6-phosphogluconate dehydrogenase ( 6PGD ) is upregulated aberrantly in the neointimal layer of diseased human coronary arteries with extensive intimal hyperplasia (IH). (A) Representative immunohistochemical staining of 6PGD in cross-sections from human coronary arteries with or without severe IH lesions. Negative control staining followed the same procedures, with the exception that the primary antibody was omitted. Dashed lines highlight the internal and external elastic laminae (EEL). Tunica intima ( Int ), media ( M ), and adventitia ( Adv ) are annotated, respectively. (B) The quantification of 6PGD expression level in tunica intima area and tunica media area. Positive staining was assessed based on colorimetric intensity per image field, quantified by averaging three sections from each sample. The resulting averages from all four unique donors (each including healthy vs diseased arterial segments with severe IH) were then further averaged, as illustrated in the scatter plots. (C) Representative confocal images of 6PGD (red channel) and vascular smooth muscle cell (VSMC) marker α smooth muscle actin ( α-SMA ) (green channel) costaining in healthy vs diseased (with IH lesions) human coronary arteries. Student t test: ∗∗ P < .01, ∗∗∗ P < .001. Mag , magnification.

    Journal: JVS-Vascular Science

    Article Title: The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia

    doi: 10.1016/j.jvssci.2024.100214

    Figure Lengend Snippet: Pentose phosphate pathway (PPP) enzyme 6-phosphogluconate dehydrogenase ( 6PGD ) is upregulated aberrantly in the neointimal layer of diseased human coronary arteries with extensive intimal hyperplasia (IH). (A) Representative immunohistochemical staining of 6PGD in cross-sections from human coronary arteries with or without severe IH lesions. Negative control staining followed the same procedures, with the exception that the primary antibody was omitted. Dashed lines highlight the internal and external elastic laminae (EEL). Tunica intima ( Int ), media ( M ), and adventitia ( Adv ) are annotated, respectively. (B) The quantification of 6PGD expression level in tunica intima area and tunica media area. Positive staining was assessed based on colorimetric intensity per image field, quantified by averaging three sections from each sample. The resulting averages from all four unique donors (each including healthy vs diseased arterial segments with severe IH) were then further averaged, as illustrated in the scatter plots. (C) Representative confocal images of 6PGD (red channel) and vascular smooth muscle cell (VSMC) marker α smooth muscle actin ( α-SMA ) (green channel) costaining in healthy vs diseased (with IH lesions) human coronary arteries. Student t test: ∗∗ P < .01, ∗∗∗ P < .001. Mag , magnification.

    Article Snippet: Human aortic smooth muscle cells (AoSMCs, CC-2571), smooth muscle cell basal medium (SmBM, CC-3181), and SmBM plus SingleQuots of supplements (CC-3182) were purchased from Lonza (Basel, Switzerland).

    Techniques: Immunohistochemical staining, Staining, Negative Control, Expressing, Marker

    6-Phosphogluconate dehydrogenase ( 6PGD ) silencing diminishes 6PGD enzyme activity and blocks vascular smooth muscle cell (VSMC) phenotypic switching and ERK/MEK signaling in VSMCs in vitro. Primary culture of human aortic smooth muscle cells (AoSMCs) were subjected to serum starvation for 24 hours before the treatment with 6PGD-specific small interfering RNA ( si-6PGD ) or scramble control ( SCR ). After 24 hours of treatment, platelet-derived growth factor (PDGF-BB) was introduced to induce AoSMC dysfunction for an additional 24 hours. (A and B) Representative Western blot images and protein-level quantitation of phosphorylated-ERK ( P-ERK ), total-ERK ( T-ERK ), phosphorylated-MEK ( P-MEK ), total-MEK ( T-MEK ), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (C) Enzymatic activity of 6PGD was assayed following the manufacturer's instructions. In brief, cell samples were lysed using assay buffer, mixed with the reaction mix, and absorbance was measured at 460 nm in kinetic mode for 60 minutes at 37°C. (D) Representative images of VSMC migration in the transwell assays and quantitation. (E) Quantitation of VSMC proliferation after si-6PGD or SCR treatment, with or without PDGF-BB stimulation. (F) Quantitative polymerase chain reaction analysis of messenger RNA levels of VSMC differentiation marker α smooth muscle actin ( α-SMA ), dedifferentiation marker ALDH1A3, and inflammation marker ICAM1. The data are presented as mean ± standard deviation (n = 3-8 replicates as represented by the scatter plots), and statistical analyses were performed using one-way analysis of variance with post hoc Tukey test. ns , not significant. ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.

    Journal: JVS-Vascular Science

    Article Title: The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia

    doi: 10.1016/j.jvssci.2024.100214

    Figure Lengend Snippet: 6-Phosphogluconate dehydrogenase ( 6PGD ) silencing diminishes 6PGD enzyme activity and blocks vascular smooth muscle cell (VSMC) phenotypic switching and ERK/MEK signaling in VSMCs in vitro. Primary culture of human aortic smooth muscle cells (AoSMCs) were subjected to serum starvation for 24 hours before the treatment with 6PGD-specific small interfering RNA ( si-6PGD ) or scramble control ( SCR ). After 24 hours of treatment, platelet-derived growth factor (PDGF-BB) was introduced to induce AoSMC dysfunction for an additional 24 hours. (A and B) Representative Western blot images and protein-level quantitation of phosphorylated-ERK ( P-ERK ), total-ERK ( T-ERK ), phosphorylated-MEK ( P-MEK ), total-MEK ( T-MEK ), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (C) Enzymatic activity of 6PGD was assayed following the manufacturer's instructions. In brief, cell samples were lysed using assay buffer, mixed with the reaction mix, and absorbance was measured at 460 nm in kinetic mode for 60 minutes at 37°C. (D) Representative images of VSMC migration in the transwell assays and quantitation. (E) Quantitation of VSMC proliferation after si-6PGD or SCR treatment, with or without PDGF-BB stimulation. (F) Quantitative polymerase chain reaction analysis of messenger RNA levels of VSMC differentiation marker α smooth muscle actin ( α-SMA ), dedifferentiation marker ALDH1A3, and inflammation marker ICAM1. The data are presented as mean ± standard deviation (n = 3-8 replicates as represented by the scatter plots), and statistical analyses were performed using one-way analysis of variance with post hoc Tukey test. ns , not significant. ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.

    Article Snippet: Human aortic smooth muscle cells (AoSMCs, CC-2571), smooth muscle cell basal medium (SmBM, CC-3181), and SmBM plus SingleQuots of supplements (CC-3182) were purchased from Lonza (Basel, Switzerland).

    Techniques: Activity Assay, In Vitro, Small Interfering RNA, Control, Derivative Assay, Western Blot, Quantitation Assay, Migration, Real-time Polymerase Chain Reaction, Marker, Standard Deviation

    Small molecular inhibitor Physcion treatment phenocopies 6-phosphogluconate dehydrogenase ( 6PGD ) loss-of-function against vascular smooth muscle cell (VSMC) phenotypic switching in vitro. Human aortic smooth muscle cells (AoSMCs) underwent serum starvation for 24 hours before treatment with Physcion or DMSO vehicle control. After 24 hours of treatment with Physcion (100 nM) or control, platelet-derived growth factor ( PDGF-BB ) was introduced to induce VSMC's hyperproliferative and migratory phenotypic switching for an additional 24 hours. (A ) Representative Western blot images of phosphorylated-ERK ( P-ERK ), total-ERK ( T-ERK ), phosphorylated-MEK ( P-MEK ), and total-MEK ( T-MEK ). ( B ) Enzymatic activity of 6PGD. (C) Protein quantitation of P-ERK and P-MEK (normalized to T-ERK and T-MEK, respectively). (D) Representative images of VSMC migration in the Transwell assays and quantitation. (E) Quantitation of VSMC proliferation following Physcion or vehicle control treatment, with or without PDGF-BB stimulation. The data is presented as mean ± standard deviation (n ≥ 3 replicates), and statistical analysis was performed using one-way analysis of variance with post hoc Tukey test. ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.

    Journal: JVS-Vascular Science

    Article Title: The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia

    doi: 10.1016/j.jvssci.2024.100214

    Figure Lengend Snippet: Small molecular inhibitor Physcion treatment phenocopies 6-phosphogluconate dehydrogenase ( 6PGD ) loss-of-function against vascular smooth muscle cell (VSMC) phenotypic switching in vitro. Human aortic smooth muscle cells (AoSMCs) underwent serum starvation for 24 hours before treatment with Physcion or DMSO vehicle control. After 24 hours of treatment with Physcion (100 nM) or control, platelet-derived growth factor ( PDGF-BB ) was introduced to induce VSMC's hyperproliferative and migratory phenotypic switching for an additional 24 hours. (A ) Representative Western blot images of phosphorylated-ERK ( P-ERK ), total-ERK ( T-ERK ), phosphorylated-MEK ( P-MEK ), and total-MEK ( T-MEK ). ( B ) Enzymatic activity of 6PGD. (C) Protein quantitation of P-ERK and P-MEK (normalized to T-ERK and T-MEK, respectively). (D) Representative images of VSMC migration in the Transwell assays and quantitation. (E) Quantitation of VSMC proliferation following Physcion or vehicle control treatment, with or without PDGF-BB stimulation. The data is presented as mean ± standard deviation (n ≥ 3 replicates), and statistical analysis was performed using one-way analysis of variance with post hoc Tukey test. ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.

    Article Snippet: Human aortic smooth muscle cells (AoSMCs, CC-2571), smooth muscle cell basal medium (SmBM, CC-3181), and SmBM plus SingleQuots of supplements (CC-3182) were purchased from Lonza (Basel, Switzerland).

    Techniques: In Vitro, Control, Derivative Assay, Western Blot, Activity Assay, Protein Quantitation, Migration, Quantitation Assay, Standard Deviation